1. Home
  2. AQST
  3. AQST News

Latest Aquestive Therapeutics Inc. (AQST) News on July 5, 2025

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
AQST

GlobeNewswire

10 days ago

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit

AQST

MT Newswires

19 days ago

Aquestive Gets FDA Acceptance of New Drug Application for Severe Allergic Reaction Treatment

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
AQST

GlobeNewswire

19 days ago

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions

Those who invested in Aquestive Therapeutics (NASDAQ:AQST) three years ago are up 128%
AQST

Simply Wall St.

a month ago

Those who invested in Aquestive Therapeutics (NASDAQ:AQST) three years ago are up 128%

Aquestive Therapeutics, Inc. (AQST): Analysts See 245% Upside Potential
AQST

Insider Monkey

a month ago

Aquestive Therapeutics, Inc. (AQST): Analysts See 245% Upside Potential

AQST

GuruFocus.com

2 months ago

Aquestive Therapeutics Inc (AQST) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines ...

Aquestive Therapeutics (AQST) Reports Q1 Earnings: What Key Metrics Have to Say
AQST

Zacks

2 months ago

Aquestive Therapeutics (AQST) Reports Q1 Earnings: What Key Metrics Have to Say

Aquestive Therapeutics (AQST) Reports Q1 Loss, Lags Revenue Estimates
AQST

Zacks

2 months ago

Aquestive Therapeutics (AQST) Reports Q1 Loss, Lags Revenue Estimates

AQST

Associated Press Finance

2 months ago

Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
AQST

GlobeNewswire

2 months ago

Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Earnings To Watch: Aquestive Therapeutics Inc (AQST) Reports Q1 2025 Result
AQST

GuruFocus.com

2 months ago

Earnings To Watch: Aquestive Therapeutics Inc (AQST) Reports Q1 2025 Result

Aquestive Therapeutics Inc (AQST) Q1 2025: Everything You Need To Know Ahead Of Earnings
AQST

GuruFocus.com

2 months ago

Aquestive Therapeutics Inc (AQST) Q1 2025: Everything You Need To Know Ahead Of Earnings

Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
AQST

GlobeNewswire

2 months ago

Aquestive Therapeutics to Participate in Citizens Life Sciences Conference

Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET
AQST

GlobeNewswire

2 months ago

Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET

Strength Seen in Recursion Pharmaceuticals (RXRX): Can Its 27.7% Jump Turn into More Strength?
AQST

Zacks

3 months ago

Strength Seen in Recursion Pharmaceuticals (RXRX): Can Its 27.7% Jump Turn into More Strength?

Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
AQST

GlobeNewswire

3 months ago

Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium

Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film
AQST

GlobeNewswire

3 months ago

Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film

Earnings Update: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Are Trimming Their Forecasts
AQST

Simply Wall St.

4 months ago

Earnings Update: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Are Trimming Their Forecasts

AQST

GuruFocus.com

4 months ago

Aquestive Therapeutics Inc (AQST) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

AQST

MT Newswires

4 months ago

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

AQST

MT Newswires

4 months ago

Aquestive Therapeutics Q4 Net Loss Widens, Revenue Falls; 2025 Revenue Outlook Issued

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics
AQST

Zacks

4 months ago

Compared to Estimates, Aquestive Therapeutics (AQST) Q4 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates
AQST

Zacks

4 months ago

Aquestive Therapeutics (AQST) Reports Q4 Loss, Lags Revenue Estimates

AQST

Associated Press Finance

4 months ago

Aquestive Therapeutics: Q4 Earnings Snapshot

Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
AQST

GlobeNewswire

4 months ago

Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

AQST

GuruFocus.com

4 months ago

What To Expect From Aquestive Therapeutics Inc (AQST) Q4 2024 Earnings

AQST

GuruFocus.com

4 months ago

Aquestive Therapeutics Inc (AQST) Q4 2024: Everything You Need To Know Ahead Of Earnings

Aquestive Therapeutics to Participate in Two Upcoming Conferences in March
AQST

GlobeNewswire

4 months ago

Aquestive Therapeutics to Participate in Two Upcoming Conferences in March

Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
AQST

GlobeNewswire

5 months ago

Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET

Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?
AQST

Zacks

5 months ago

Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?

Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
AQST

GlobeNewswire

5 months ago

Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting

Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Conference
AQST

GlobeNewswire

5 months ago

Aquestive Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Conference

Institutional investors own a significant stake of 49% in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
AQST

Simply Wall St.

5 months ago

Institutional investors own a significant stake of 49% in Aquestive Therapeutics, Inc. (NASDAQ:AQST)

Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives
AQST

GlobeNewswire

6 months ago

Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives

AQST

MT Newswires

7 months ago

Sector Update: Health Care Stocks Lower Thursday Afternoon

Aquestive Therapeutics Gains FDA Orphan Drug Exclusivity for Pediatric Seizure Treatment
AQST

GuruFocus.com

7 months ago

Aquestive Therapeutics Gains FDA Orphan Drug Exclusivity for Pediatric Seizure Treatment

AQST

MT Newswires

7 months ago

Aquestive Therapeutics Says FDA Grants Orphan Drug Exclusivity for Libervant Buccal Film to Treat Seizure Clusters

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five
AQST

GlobeNewswire

7 months ago

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant® (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five

Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside
AQST

Benzinga

7 months ago

Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside

AQST

MT Newswires

7 months ago

Cantor Fitzgerald Initiates Aquestive Therapeutics at Overweight With $17 Price Target

Aquestive Therapeutics' (NASDAQ:AQST) investors will be pleased with their favorable 88% return over the last year
AQST

Simply Wall St.

7 months ago

Aquestive Therapeutics' (NASDAQ:AQST) investors will be pleased with their favorable 88% return over the last year

AQST

MT Newswires

7 months ago

Aquestive Therapeutics Receives FDA 'Positive Feedback' for Anaphylm Sublingual Film

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film
AQST

GlobeNewswire

7 months ago

Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm™ (epinephrine) Sublingual Film

Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025?
AQST

Insider Monkey

8 months ago

Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025?

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
AQST

GlobeNewswire

8 months ago

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

Aquestive Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
AQST

Simply Wall St.

8 months ago

Aquestive Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

AQST

GuruFocus.com

8 months ago

Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ...

Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
AQST

Zacks

8 months ago

Aquestive Therapeutics (AQST) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates
AQST

Zacks

8 months ago

Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates

AQST

Associated Press Finance

8 months ago

Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
AQST

GlobeNewswire

8 months ago

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Report Preview: What To Expect
AQST

GuruFocus.com

8 months ago

Aquestive Therapeutics Inc (AQST) Q3 2024 Earnings Report Preview: What To Expect

Aquestive Therapeutics Inc (AQST) Q3 2024: Everything You Need To Know Ahead Of Earnings
AQST

GuruFocus.com

8 months ago

Aquestive Therapeutics Inc (AQST) Q3 2024: Everything You Need To Know Ahead Of Earnings

Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study
AQST

TipRanks

8 months ago

Aquestive Therapeutics’ Breakthrough in Allergy Treatment Study

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting
AQST

GlobeNewswire

8 months ago

Aquestive Therapeutics to Present Subsequent Analysis of Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Demonstrating Comparable PK and PD Data to Epinephrine Injection Regardless of Variable Placement or Intraoral Movement at American College of Allergy Asthma and Immunology (ACAAI) 2024 Annual Meeting

Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film
AQST

GlobeNewswire

8 months ago

Aquestive Therapeutics Announces Positive Topline Results from Oral Allergy Syndrome (OAS) Challenge Study for Anaphylm™ (epinephrine) Sublingual Film

Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET
AQST

GlobeNewswire

8 months ago

Aquestive Therapeutics to Report Third Quarter 2024 Financial Results and Recent Business Highlights on November 4 and Host Conference Call on November 5 at 8:00 a.m. ET

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
AQST

Benzinga

9 months ago

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day
AQST

GlobeNewswire

9 months ago

Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day

Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th
AQST

GlobeNewswire

10 months ago

Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences
AQST

GlobeNewswire

10 months ago

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™

Aquestive Therapeutics Second Quarter 2024 Earnings: Beats Expectations
AQST

Simply Wall St.

a year ago

Aquestive Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Aquestive Therapeutics (AQST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
AQST

Zacks

a year ago

Aquestive Therapeutics (AQST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates
AQST

Zacks

a year ago

Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates

AQST

Associated Press Finance

a year ago

Aquestive Therapeutics: Q2 Earnings Snapshot

Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Institutions profited after Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) market cap rose US$72m last week but retail investors profited the most
AQST

Simply Wall St.

a year ago

Institutions profited after Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) market cap rose US$72m last week but retail investors profited the most

Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study

Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET

New Strong Sell Stocks for July 11th
AQST

Zacks

a year ago

New Strong Sell Stocks for July 11th

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows
AQST

Benzinga

a year ago

Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows

Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film

Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years
AQST

Simply Wall St.

a year ago

Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years

AQST

MT Newswires

a year ago

Aquestive Therapeutics to Join Russell 3000, Russell 2000 on July 1

Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
AQST

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
AQST

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23
AQST

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
AQST

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May
AQST

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
AQST

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
AQST

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed
AQST

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference

5 Small Drug Stocks to Buy From a Recovering Industry
AQST

Zacks

a year ago

5 Small Drug Stocks to Buy From a Recovering Industry

AQST

MT Newswires

a year ago

Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript
AQST

Insider Monkey

a year ago

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
AQST

Simply Wall St.

a year ago

Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

AQST

GuruFocus.com

a year ago

Aquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
AQST

Zacks

a year ago

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates
AQST

Zacks

a year ago

Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates

AQST

Associated Press Finance

a year ago

Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
AQST

GlobeNewswire

a year ago

Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
AQST

Zacks

a year ago

Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?

Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
AQST

Zacks

a year ago

Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for
AQST

Zacks

a year ago

Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for

Share on Social Networks: